Glaxo rotavirus vaccine highly effective

GlaxoSmithKline Plc's Rotarix vaccine given along with other routine infant shots is highly effective at protecting against rotavirus, the most common cause of severe diarrhoea in young children.

New data from a large European trial, published in the Lancet journal, showed the oral vaccine worked against the five most commonly circulating rotavirus types -- G1, G2, G3, G4 and G9 -- responsible for 98 percent of rotavirus gastroenteritis. More

Comments

Popular posts from this blog

Databases on the FDA Website

IPEXL - New Patent Search Tool

Employee Retention – A critical issue, why..and How to solve?